Ventum Financial set a C$60.00 target price on Calian Group (TSE:CGY – Free Report) in a report released on Wednesday,BayStreet.CA reports. The firm currently has a buy rating on the stock.
CGY has been the subject of several other research reports. Royal Bank of Canada decreased their price objective on shares of Calian Group from C$60.00 to C$58.00 and set an “outperform” rating for the company in a research note on Thursday, May 22nd. Desjardins dropped their price objective on shares of Calian Group from C$82.00 to C$61.00 and set a “buy” rating on the stock in a report on Thursday, May 22nd. Canaccord Genuity Group dropped their price target on shares of Calian Group from C$75.00 to C$60.00 and set a “buy” rating on the stock in a research report on Thursday, May 22nd. Finally, CIBC reduced their price target on shares of Calian Group from C$63.00 to C$62.00 in a research report on Friday, February 14th. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Calian Group currently has a consensus rating of “Buy” and a consensus price target of C$63.43.
Get Our Latest Analysis on Calian Group
Calian Group Trading Up 1.9%
Calian Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 10th. Shareholders of record on Tuesday, June 10th were issued a dividend of $0.28 per share. The ex-dividend date was Tuesday, May 27th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 2.37%. Calian Group’s dividend payout ratio (DPR) is 119.93%.
Insider Buying and Selling at Calian Group
In related news, Senior Officer Kevin Lee Ford purchased 1,000 shares of the firm’s stock in a transaction that occurred on Friday, May 23rd. The stock was acquired at an average cost of C$38.37 per share, for a total transaction of C$38,370.00. In the last 90 days, insiders have purchased 2,934 shares of company stock valued at $116,566. Company insiders own 0.63% of the company’s stock.
Calian Group Company Profile
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.
See Also
- Five stocks we like better than Calian Group
- How Technical Indicators Can Help You Find Oversold Stocks
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
- The 3 Best Fintech Stocks to Buy Now
- Upstart Stock’s Bull Case Just Got a Lot Stronger
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Higher Gulf Oil Output Puts These Energy Names in Play
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.